AMBER CANO: Open Payments
NPI 1518618057 · AVONDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,447 in 150 payments from 45 companies in 2025. Trend: 2023 $1,303 · 2024 $3,603 · 2025 $3,447
Food & beverage: $3,304Education: $143
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $318 |
| Janssen Biotech, Inc. | 13 | $246 |
| JAZZ PHARMACEUTICALS INC. | 6 | $221 |
| Daiichi Sankyo Inc. | 9 | $221 |
| GENZYME CORPORATION | 7 | $182 |
| Novartis Pharmaceuticals Corporation | 10 | $177 |
| Lilly USA, LLC | 6 | $168 |
| Merck Sharp & Dohme LLC | 7 | $150 |
| ABBVIE INC. | 7 | $117 |
| Aveo Pharmaceuticals, Inc. | 2 | $116 |
Products named: Enhertu, ZIIHERA, VERZENIO, FOTIVDA, KEYTRUDA, DARZALEX, WAYRILZ, EPKINLY.
Industry payments across AZ — which companies pay providers there.
